Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients
Nowadays neoadjuvant immunotherapy is one of the main research areas in oncology. This interest is supported by the success of check-point inhibitors in treatment of advanced and metastatic lung cancer. The postulate that neoadjuvant immunotherapy achieves tumor devitalization before surgery is conf...
| Huvudupphovsmän: | , , , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | Russian |
| Publicerad: |
Remedium Group LLC
2019-12-01
|
| Serie: | Медицинский совет |
| Ämnen: | |
| Länkar: | https://www.med-sovet.pro/jour/article/view/5047 |